Last reviewed · How we verify

NCT06875505: PAPEsoccer

Post-activation Performance Enhancement in Soccer Players:

Active, enrolled NA Last updated 13 March 2025
What this trial tests

NA trial testing Dynamic PAPE in Performance in 25 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
20 February 2025
Primary endpoint
15 April 2025
25 April 2025

Quick facts

Lead sponsorKarabuk University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposetreatment
Enrollment25
Start date20 February 2025
Primary completion15 April 2025
Estimated completion25 April 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Karabuk University

Who can join

Adults 18 to 24, male only, with Performance or Post Activation Potentiation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be conducted in a randomised, crossover design. Soccer players will participate in two test sessions 48 hours apart. The athletes will be pre-tested in the professional direction change test and after the PAPE protocol of the group they are included in is applied, they will be taken to the professional direction change test at 15th second, 3rd, 6th, 9th and 12th minutes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Performance

Currently open trials in the same condition.

Other Karabuk University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06875505.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing